Accounts Payable / Remittance Processing

PRODUCTS

  • Isolator systems are becoming increasingly important to the pharmaceutical industry. The improvement in product quality, the reduction of operating costs and the capability of longer production runs are significant advantages in comparison to conventional clean room production.

  • Development beyond traditional monoclonal antibodies (mAbs) is increasing, and today, we see antibody variants like multi-specific and bispecific antibodies and antibody fragments.

  • Revolutionizing Global mRNA Production: Germfree's Innovative Cleanrooms Drive Manufacturing Success

    Cleanroom requirements for mRNA manufacturing encompass stringent particle control, temperature and humidity management, solvent management and robust contamination prevention strategies. Germfree’s advanced cleanroom solutions address these challenges, ensuring seamless equipment integration, process adaptability, and compliance with regulatory standards. Their tailored mobile and modular facilities support the emerging trend for localized vaccine production, empowering biopharmaceutical companies to harness the transformative potential of mRNA technology in a rapidly advancing field, and ultimately contributing to global immunization efforts.

  • Protein A chromatography resin with enhanced alkaline stability and binding capacity for improved process economy in antibody purification.

  • For even smaller batches, the gloveless microBatch working cell is the perfect solution. The setup allows fast installation/validation as well as 100% in-process check weighing. A fully integrated machine and Isolator unit are key to ensure quality and output.

WHITE PAPERS AND CASE STUDIES

NEWS